How long can I take Semaglutide for weight loss
So when you suppress GLP-1 with an injectable, you're actually suppressing five hormones, not just one
Unlike traditional GLP-1 agonists that target a single receptor pathway, tirzepatide simultaneously activates both GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptors
Most people find the needle itself causes very little discomfort
The Phase 2 MASH trial (published in NEJM) This 48-week randomized, double-blind, placebo-controlled trial enrolled 293 adults with biopsy-confirmed MASH and fibrosis stages F1 through F3
Quick Answer: Tirzepatide injection site itching is a common adverse reaction affecting up to 1 in 10 patients, typically caused by localised immune responses, excipient sensitivity, or mechanical tissue irritation